SCHEMBL2373340

SCHEMBL2373340

CCC[C@H](NC(=O)CC[C@H](NC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)O)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 8/20 0.69
▸ NOD1 Q9Y239 8/20 0.52
▸ CCKAR P32238 4/20 0.46
▸ CCKBR P32239 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12296114 0.96 GLP1R (0.75) GLP1RNOD1CCKARCCKBR
SCHEMBL12295757 0.96 GLP1R (0.75) GLP1RNOD1CCKARCCKBR
SCHEMBL12296111 0.96 GLP1R (0.75) GLP1RNOD1CCKARCCKBR
SCHEMBL21754511 0.96 GLP1R (0.69) GLP1RNOD1CCKARCCKBR
SCHEMBL24301003 0.95 GLP1R (0.77) GLP1RNOD1CCKARCCKBR
SCHEMBL12295237 0.95 GLP1R (0.77) GLP1RNOD1CCKARCCKBR
SCHEMBL12295570 0.95 GLP1R (0.77) GLP1RNOD1CCKARCCKBR
SCHEMBL12295341 0.95 GLP1R (0.77) GLP1RNOD1CCKARCCKBR
SCHEMBL21242887 0.95 GLP1R (0.77) GLP1RNOD1CCKARCCKBR
SCHEMBL21242650 0.95 GLP1R (0.77) GLP1RNOD1CCKARCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011117416-A1 NOVEL GLUCAGON ANALOGUES NOVO NORDISK A/S (DK) 2011-09-29 — — WO claimed
EP-2758426-A1 NOVEL GLUCAGON ANALOGUES Novo Nordisk A/S (DK) 2014-07-30 — — EP disclosed
WO-2013041678-A1 NOVEL GLUCAGON ANALOGUES NOVO NORDISK A/S (DK) 2013-03-28 — — WO disclosed
EP-2552951-A1 NOVEL GLUCAGON ANALOGUES Novo Nordisk A/S (DK) 2013-02-06 — — EP disclosed
WO-2011117416-A1 NOVEL GLUCAGON ANALOGUES NOVO NORDISK A/S (DK) 2011-09-29 — — WO disclosed
Send feedback